Group 1 - Tecan Group successfully raised CHF 150 million through the issuance of a fixed rate domestic straight bond with a coupon of 0.850% and a duration of 5 years [1][2] - The net proceeds from the bond issuance will be used for general corporate purposes, including the repayment of an outstanding CHF 250 million bond maturing in October 2025 [2] - The bonds were placed with institutional investors and private banks in Switzerland, managed by UBS Investment Bank and Zürcher Kantonalbank, with Bank J. Safra Sarasin as Co-Lead Manager [2] Group 2 - Tecan is a global leader in laboratory automation, improving healthcare innovation from life science to clinical applications [3] - Founded in Switzerland in 1980, Tecan has over 3,000 employees and operates manufacturing, research, and development sites in Europe, North America, and Asia [3] - In 2024, Tecan generated sales of CHF 934 million (USD 1,062 million; EUR 984 million) [3]

Core Viewpoint - Wendel is planning to launch a potential €500 million 8-year bond issue, subject to market conditions, and intends to redeem existing bonds maturing in February 2027 with an outstanding principal of €500 million [1][2]. Group 1: Bond Issue Details - The new bond issue, referred to as the "2033 Bond Issue," is expected to have a nominal amount of €500 million and will be conducted by several financial institutions including Crédit Agricole Corporate and Investment Bank and Société Générale [1][3]. - Wendel plans to exercise an early make-whole redemption option on the existing bonds with a 2.50% interest rate, maturing in February 2027, at a price determined by the bond's terms and conditions [2][3]. Group 2: Financial Strategy - The transactions related to the bond issue will allow Wendel to extend the average maturity of its bond debt, enhancing its financial flexibility [3].

Core Viewpoint - Sanofi has successfully priced a €1.5 billion bond issue, which will be utilized for general corporate purposes [1]. Group 1: Bond Issue Details - The bond issue consists of two tranches, each amounting to €750 million [7]. - The first tranche is due in June 2029 with an annual interest rate of 2.625% [7]. - The second tranche is due in June 2032 with an annual interest rate of 3.000% [7]. Group 2: Transaction Management - The transaction was led by Citigroup and RBC Capital Markets as Global Coordinators [2]. - Credit Agricole CIB, HSBC, and Societe Generale acted as Joint Lead Managers for the bond issue [2]. Group 3: Company Overview - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives through innovative medicines and vaccines [3]. - The company aims to address urgent healthcare, environmental, and societal challenges [3]. - Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY [3].

Core Viewpoint - Worldline, a global leader in payment services, is planning to issue a 5-year fixed rate, senior unsecured bond denominated in euros, subject to market conditions, to raise funds for general corporate purposes and potential refinancing of existing debt [1][2]. Group 1: Bond Issuance Details - The bond issuance is expected to be admitted to trading on the regulated market of the Luxembourg Stock Exchange [2]. - The net proceeds from the bond issuance will be used for general corporate purposes and to refinance existing indebtedness, including €800 million Convertible/Exchangeable Bonds due July 30, 2026 [2][3]. - Worldline may also consider buying back some of its outstanding Convertible/Exchangeable Bonds opportunistically, depending on market conditions [3]. Group 2: Regulatory and Market Considerations - The bonds are intended to be offered outside the United States under Regulation S and will not be registered under the U.S. Securities Act [6]. - The issuance is not a public offering and is restricted to qualified investors as defined by relevant regulations [4][7]. - The distribution of the press release is subject to legal restrictions in certain jurisdictions, and compliance with these restrictions is necessary [5][9]. Group 3: Company Overview - Worldline generated €4.6 billion in revenue in 2024 and aims to support sustainable economic growth through its digital payment solutions [10]. - The company focuses on providing advanced payment technology and customized solutions for various markets and industries, serving over one million businesses globally [10].